Orion Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.61K Hold
150
﹤0.01% 451
2026
Q1
$4.21K Hold
150
﹤0.01% 413
2025
Q4
$3.73K Hold
150
﹤0.01% 442
2025
Q3
$3.82K Hold
150
﹤0.01% 452
2025
Q2
$3.64K Hold
150
﹤0.01% 424
2025
Q1
$3.8K Sell
150
-21
-12% -$550 ﹤0.01% 412
2024
Q4
$4.54K Buy
+171
New +$4.64K ﹤0.01% 409
2024
Q3
Sell
-171
Closed -$4.79K 344
2024
Q2
$4.79K Hold
171
﹤0.01% 380
2024
Q1
$4.75K Sell
171
-1,790
-91% -$49.7K ﹤0.01% 425
2023
Q4
$56.5K Sell
1,961
-5,130
-72% -$155K 0.03% 224
2023
Q3
$235K Sell
7,091
-2,910
-29% -$103K 0.15% 104
2023
Q2
$367K Sell
10,001
-2,479
-20% -$96.5K 0.24% 85
2023
Q1
$509K Sell
12,480
-300
-2% -$13K 0.34% 58
2022
Q4
$655K Hold
12,780
0.48% 49
2022
Q3
$559K Buy
12,780
+3,010
+31% +$146K 0.45% 49
2022
Q2
$512K Buy
9,770
+1,000
+11% +$51K 0.4% 49
2022
Q1
$454K Buy
8,770
+2,380
+37% +$123K 0.27% 67
2021
Q4
$377K Buy
6,390
+490
+8% +$24.3K 0.21% 83
2021
Q3
$254K Hold
5,900
0.15% 99
2021
Q2
$231K Buy
5,900
+5,100
+638% +$198K 0.14% 102
2021
Q1
$29K Hold
800
0.02% 195
2020
Q4
$29K Buy
+800
New +$29.3K 0.02% 186

Other funds holding PFE

Orion Capital Management's PFE Position: Q2 2026 in Review

Orion Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 150 shares worth $3.61K. The position accounts for ﹤0.01% of the portfolio, ranked #451.

Orion Capital Management first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $655K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Orion Capital Management held 150 shares of Pfizer worth $3.61K as of Q2 2026.
  • Orion Capital Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Orion Capital Management's portfolio in Q2 2026, its #451 holding.
  • Orion Capital Management first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Orion Capital Management's Pfizer position peaked at $655K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Orion Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.